TCR2 Therapeutics | 4:持股变动声明-股东 TANG KEVIN C
02/14 17:29 (美东)
TCR2 Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0%),TANG CAPITAL MANAGEMENT, LLC(0%)等
02/14 16:03 (美东)
TCR2 Therapeutics | 4:持股变动声明-股东 UBS Oncology Impact Fund L.P.
2023/06/05 16:37 (美东)
TCR2 Therapeutics | 4:持股变动声明-股东 MPM SunStates Fund, L.P.
2023/06/05 16:36 (美东)
TCR2 Therapeutics | 4:持股变动声明-股东 MPM BioVentures 2014, L.P.
2023/06/05 16:36 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 GADICKE ANSBERT
2023/06/05 16:35 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 Allen Andrew R
2023/06/01 16:33 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 Tomasello Shawn
2023/06/01 16:32 (美东)
TCR2 Therapeutics | 4:持股变动声明-首席财务官 Sullivan Eric
2023/06/01 16:31 (美东)
TCR2 Therapeutics | 4:持股变动声明-高管 Cardama Alfonso Quintas
2023/06/01 16:29 (美东)
TCR2 Therapeutics | 4:持股变动声明-首席运营官 Olagunju Peter
2023/06/01 16:27 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 Webster Stephen W
2023/06/01 16:25 (美东)
TCR2 Therapeutics | 4:持股变动声明-高管 Harrison Rosemary
2023/06/01 16:23 (美东)
TCR2 Therapeutics | 4:持股变动声明-高管 Menzel Garry E
2023/06/01 16:22 (美东)
TCR2 Therapeutics | 4:持股变动声明-首席人事官 Justice Angela
2023/06/01 16:21 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 Hoos Axel
2023/06/01 16:20 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 Hegde Priti
2023/06/01 16:18 (美东)
TCR2 Therapeutics | 4:持股变动声明-董事 Gibson Neil W
2023/06/01 16:15 (美东)
TCR2 Therapeutics | 4:持股变动声明-股东 TANG KEVIN C
2023/05/30 20:02 (美东)
TCR2 Therapeutics | 4:持股变动声明-股东 MPM ASSET MANAGEMENT LLC
2023/05/24 16:39 (美东)
暂无数据
暂无数据